Artículos de revistas
Long-term Follow-up Of An 8-year-old Boy With Insulinoma As The First Manifestation Of A Familial Form Of Multiple Endocrine Neoplasia Type 1 [seguimento De Longo Prazo Em Um Menino De 8 Anos De Idade Com Insulinoma Como Primeira Manifestação De Neoplasia Endócrina Múltipla Tipo 1]
Registro en:
Arquivos Brasileiros De Endocrinologia E Metabologia. , v. 54, n. 8, p. 754 - 760, 2010.
42730
10.1590/S0004-27302010000800016
2-s2.0-79951991143
Autor
Fabbri H.C.
de Mello M.P.
Soardi F.C.
Esquiaveto-Aun A.M.
de Oliveira D.M.
Denardi F.C.
Moura-Neto A.
Garmes H.M.
Baptista M.T.M.
de Matos P.S.
de Lemos-Marini S.H.V.
D'Souza-Li L.F.R.
Guerra-Junior G.
Institución
Resumen
Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant hereditary cancer syndrome characterized mostly by parathyroid, enteropancreatic, and anterior pituitary tumors. We present a case of an 8-year-old boy referred because of hypoglycemic attacks. His diagnosis was pancreatic insulinoma. Paternal grandmother died due to repeated gastroduodenal ulcerations and a paternal aunt presented similar manifestations. At a first evaluation, the father presented only gastric ulceration but subsequently developed hyperparathyroidism and lung carcinoid tumor. During almost 15 years of follow-up, three brothers and the index case presented hyperparathyroidism and hyperprolactinemia. Molecular study showed a G to A substitution in intron 4, at nine nucleotides upstream of the splicing acceptor site, causing a splicing mutation. All affected members of the family have the same mutation. Paternal grandmother and aunt were not studied and the mother does not carry any mutation. MEN1 is a rare condition that requires permanent medical assistance. Early clinical and genetic identification of affected individuals is essential for their own surveillance and also for genetic counseling. © ABE&M todos os direitos reservados. 54 8 754 760 Carling, T., Multiple endocrine neoplasia syndrome: Genetic basis for clinical management (2005) Curr Opin Oncol, 17, pp. 7-12 Guang-Wen, Z., Yao, W., Xi, C., Xiao-Hua, J., Xiao-Ying, L., Guang, N., Diagnosis and surgical treatment of multiple endocrine neoplasia (2009) Chin Med J, 122, pp. 1495-1500 Brandi, M.L., Gagel, R.F., Angell, A., Bilczikian, J.P., Beck-Peccoz, P., Bordi, C., Consensus: Guidelines for diagnosis and therapy of MEN type 1 and type 2 (2001) J Clin Endocrinol Metab, 86, pp. 5658-5671 Newey, P.J., Jeyabalan, J., Walls, G.V., Christie, P.T., Gleeson, F.V., Gould, S., Nonfunctioning tumors in children with MEN1 (2009) J Clin Endocrinol Metab, 94, pp. 3640-3646 Corbetta, S., Pizzocaro, A., Beck-Peccoz, P.P., Faglia, G., Spada, A., Multiple endocrine neoplasia type 1 in patients with recognized pituitary tumours of different types (1997) Clin Endocrinol, 47, pp. 507-512 Yoshimoto, K., Saito, S., Clinical characteristics in multiple endocrine neoplasia type 1 in Japan: A review of 106 patients (1991) Nippon Naibunpi Gakkai Zasshi, 67, pp. 764-774 Marx, S.J., Spiegel, A.M., Skarulis, M.C., Doppman, J.L., Collins, P.S., Liotta, L.A., Multiple endocrine neoplasia type 1: Clinical and genetic topics (1998) Ann Intern Med, 129, pp. 484-494 Chandrasckharappa, S.C., Guru, S.C., Manickan, P., Olufemi, S.E., Collins, P.S., Emmert-Buck, M.R., Positional cloning of the gene for multiple endocrine neoplasia-type 1 (1997) Science, 276, pp. 404-407 Franchi, G.M., Villa, V.V., Carrera, P., Sartorio, S.M., Maffi, P., Bosi, E., A new mutation in the MEN1 gene (2009) Cancer Genet Cytogenet, 192, pp. 199-201 Kim, H., Lee, J.R., Cho, E.J., Liu, J.O., Youn, H.D., Menin, a tumor suppressor, represses JunD-mediated transcriptional activity by association with mSln3A-histonic deacctylase complex (2003) Cancer Res, 63, pp. 6135-6139 Falchetti, A., Marini, F., Brandi, M.L., Multiple endocrine neoplasia (2010) GeneReviews, , http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=men1, Available at, Accessed at: 27 Jul 2010 Geerdink, B.A.M., van der Luijt, R.B., Lips, C.J.M., Do patients with multiple endocrine neoplasia syndrome type 1 benefit from periodical screening? (2003) Eur J Endocrinol, 149, pp. 577-582 Falchetti, A., Brandi, M.L., Multiple endocrine neoplasia type I variants and phenocopies: More than a nosological issue? (2009) J Clin Endocrinol Metab, 94, pp. 1518-1520 Marx, S.J., Nieman, L.K., Aggressive pituitary tumours in MEN1: Do they refute the two-hit model of tmorigenesis? (2002) J Clin Endocrinol Metab, 87, pp. 453-456 Sambrook, J., Fritsch, E.F., Maniatis, T.E., Molecular cloning, a laboratory manual (1989), New York: Cold Spring HarborLourenço Jr., D.M., Coutinho, F.L., Toledo, R.A., Montenegro, F.L., Correia-Deur, J.E., Toledo, S.P., Early-onset, progressive, frequent, extensive, and severe bone mineral and renal complications in multiple endocrine neoplasia type 1-associated primary hyperparathyroidism (2010) J Bone Miner Res, 25 (11), pp. 2382-2391 Ruszniewski, P., Fave, G.D., Cadiot, G., Komminoth, P., Chung, D., Kos-Kudla, B., Well-differentiated gastric tumors/carcinomas (2006) Neuroendocrinology, 84, pp. 158-164 Schussheim, D.H., Skarulis, M.C., Agarwal, S.K., Simonds, W.F., Burns, A.L., Spiegel, A.M., Multiple endocrine neoplasia type 1: New clinical and basic findings (2001) Trends Endocrinol Metab, 12, pp. 173-178 Rix, M., Hertel, N.T., Nielsen, F.C., Jacobsen, B.B., Hoejberg, A.S., Brixen, K., Cushing's disease in childhood as the first manifestation of multiple endocrine neoplasia syndrome type 1 (2004) Eur J Endocrinol, 151, pp. 709-715 Correa, P., Lundgren, E., Rastad, J., Åkerström, G., Westin, G., Carling, T., Multiple endocrine neoplasia type 1 polymorphism D418D is associated with sporadic primary hyperparathyroidism (2002) Surgery, 132, pp. 450-455 Toledo, R.A., Lourenço, D.M., Coutinho, F.L., Quedas, E., Mackowiack, I., Machado, M.C., Novel MEN1 germline mutations in Brazilian families with multiple endocrine neoplasia type 1 (2007) Clin Endocrinol, 67, pp. 377-384 Lourenço, D.M., Toledo, R.A., Coutinho, F.L., Margarido, L.C., Siqueira, S.A., dos Santos, M.A., The impact of clinical and genetic screenings on the management of the multiple endocrine neoplasia type 1 (2007) Clinics (Sao Paulo), 62, pp. 465-476 Stratakis, C.A., Shussheim, D.H., Freedman, S.M., Keil, M.F., Pack, S.D., Agarwal, S.K., Pituitary macroadenoma in 5-year-old: An early expression of multiple endocrine neoplasia type 1 (2000) J Clin Endocrinol Metab, 85, pp. 4776-4780 Kontogeorgos, G., Kapranos, N., Tzavara, I., Thalassinos, N., Rologis, D., Monossomy of chromosome 11 in pituitary adenoma in a patient with familial multiple endocrine neoplasia type 1 (2001) Clin Endocrinol, 54, pp. 117-120 Johnston, L.B., Chew, S.L., Trainer, P.J., Reznck, R., Grossman, A.B., Besser, G.M., Screening children at risk of developing inherited endocrine neoplasia syndromes (2000) Clin Endocrinol, 52, pp. 127-136 Johnston, L.B., Chew, S.L., Lowe, D., Reznck, R., Monsom, J.P., Savage, M.O., Investigating familial endocrine neoplasia syndromes in children (2001) Horm Res, 55, pp. 31-35 Lourenço, D.M., Toledo, R.A., Mackowiak, I.I., Coutinho, F.L., Cavalcanti, M.G., Correia-Deur, J.E., Multiple endocrine neoplasia type 1 in Brazil: MEN1 founding mutation, clinical features, and bone mineral density profile (2008) Eur J Endocrinol, 159, pp. 259-274 Görtz, B., Roth, J., Speel, E.J.M., Krähemmann, A., de Krieger, R.R., Matias-Guiu, X., MEN1 gene mutation analysis of sporadic adrenocortical lesions (1999) Int J Cancer, 80, pp. 373-379 Kishi, M., Tsukada, T., Shimizu, S., Hosono, K., Ohkubo, T., Kosuge, T., A novel splicing mutation (894-9 G-A) of the MEN1 gene responsible for multiple endocrine neoplasia type 1 (1999) Cancer Letters, 142, pp. 105-110 Bassett, J.H., Forbes, S.A., Pannett, A.A., Lloyd, S.E., Christie, P.T., Wooding, C., Characterization of mutations in patients with multiple endocrine neoplasia type 1 (1998) Am J Hum Genet, 62, pp. 232-244